Friday, 20 November 2020 Central European Time (CET) 09:00-11:55 Plenary Session 1: Opening Session Hall A Chairs: Reuven Zimlichman, Giuseppe Mancia, Rimvydas Slapikas 09:00 Greetings, Chairmen 09:10 Multiple Ways by Which Sympathetic Overdrive Endangers the Cardiovascular Health Stevo Julius, USA 09:35 White Coat Hypertension, Mechanistic and Clinical Aspects Giuseppe Mancia, Italy 10:00 Cardiovascular Risk Reduction in Smokers - Never too Late Reuven Zimlichman, Israel 10:25 The New ISH Hypertension Guidelines- a Contribution to Combat Global Disease Thomas Unger, the Netherlands 10:50 Initial Hypertension Treatment. Current Guidelines and a Review of the Relevant Evidence Andrzej Januszewicz, Poland 11:15 Management of Obesity induced Hypertension and Diabetes. Practical guidelines from the ESH WG on Obesity, Diabetes and the High-Risk Patient Vasilios Kotsis, Greece 11:40 Panel Discussion and Q&A 11:55-12:10 Break, Exhibition Visit and Posters Viewing 12:10-14:05 Plenary Session 2: Arterial Hypertension and Cardiovascular Aging Hall A Chairs: Andrzej Januszewicz, Bojan Jelakovic 12:10 Vascular Aging and Disease of the Small Vessels Damiano Rizzoni, Italy 12:35 CKD and Obesity - which Equation for eGFR is Reliable Bojan Jelakovic, Croatia 13:00 The Search for Protective Factors in Individuals at High Cardiovascular Risk Peter M Nilsson, 13:25 Prediction and Prevention of Cardiometabolic Complications in Type 2 Diabetes Pavel Hamet, Canada 13:50 Panel Discussion and Q&A 1 14:05-14:30 Break, Exhibition Visit and Posters Viewing 14:30-16:45 Plenary Session 3: Hypertension and Sympathetic Nervous System Hall A Chairs: Vasilios Kotsis, Thomas Unger 14:30 24-Hour Blood Pressure Rhythms and Cardiovascular Outcomes: The Role of Age Paolo Palatini, Italy 14:50 Atherogenic Dyslipidemia, Cardiovascular Risk and Diabetes Manfredi Rizzo, Italy 15:10 Prehypertension and Arterial Hypertension among Medical Students during Training and Exams Sekib Sokolovic, Bosnia and Herzegovina 15:30 Hypertension Disorders of Pregnancy- a Major Cardiovascular Risk Alexander Prejbisz, Poland 15:50 Pharmacogenomics of Hypertension: Past Present and Future Brian Rayner, South Africa 16:10 Early Cardiovascular Structural and Functional Abnormalities as a Guide to Future Morbid Events Daniel Duprez, USA 16:30 Panel Discussion and Q&A 14:40-15:30 Parallel Abstract Session Hall B Chairs: Pavel Hamet, Damiano Rizzoni 16:45-17:45 Plenary Session 4: Sponsored Session by Kivun Acher, Israel Hall A Chairs: TBA 16:45 Harm Reduction in Smoking through Regulatory Eyes Michael Shechter, Israel Debate: Harm Reduction in Smokers 17:05 Pro Amitai Elkayam, Israel 17:20 Con Dov Gavish, Israel 17:35 Q&A and Discussion 2 17:45-19:00 Plenary Session 5: From Generation to Generation: Predisposition or Predestination? Hall A Chairs: Danuta Czarnecka, Peter Nilsson 17:45 What can we Learn from Transgenerational Studies about Cardiovascular Risk Mechanismsand the Missing Heritability Peter Nilsson, Sweden 18:05 Show me your Genes! Cardiac and Vascular Structural Changes Agnieszka Olszanecka, Poland 18:25 Neural Modulation as the Result of Parental Imprinting Katarzyna Stolarz-Skrzypek, Poland 18:45 Panel Discussion and Q&A 3 Saturday, 21 November 2020 Central European Time (CET) 09:30-11:25 Plenary Session 6: Hypertension and Arterial Properties Hall A Chairs: Carmel McEinery, Ian B Wilkinson 09:30 Haemodynamic Determinants of Longitudinal Changes in Blood Pressure Carmel McEniery, UK 09:50 Improving Risk Prediction in Borderline Hypertension with Aortic Stiffness Measurements Ian B Wilkinson, UK 10:10 Hemodynamics and Target Organ Damage in Prehypertensive Adolescents Mieczyslaw Litwin, Poland 10:30 Assessing the Impact of Switching to the Tobacco Heating System on Cardiovascular Disease: Translating Basic Science into Clinical Benefit Giuseppe Plebani, Swizerland 10:50 What is New in Peripheral Arterial Disease? Marianne Brodmann, Austria 11:10 Panel Discussion and Q&A 11:25-13:40 Plenary Session 7: Novel Pharmacological Strategies for Residual Risk Reduction: Identifying Patients and Improving Outcomes Hall A Chairs: Jelena Celutkiene, Marius Miglinas 11:25 Novel Targets in Patients with HFrEF: Essential Messeges to Clinician Jelena Celutkiene, Lithuania 11:45 Expanding the Frontiers of Type 2 Diabetes: Cardiovascular Effects of SGL2 Inibitors Jonas Ceponis, Lithuania 12:05 How does Obesity Cause Cardiovascular Disease, and what can we do about it? Coen D.A. Stehouwer, Netherlands 12:25 Management of Hypertension with Fixed Combinations Sigita Glaveckaite, Lithuania 12:45 New Era in Lipid Lowering Therapy Zaneta Petrulioniene, Lithuania 13:05 Management of Cardiovascular Risk Factors in Post ISCHAEMIA Era Rimvydas Slapikas, Lithuania 13:25 Panel Discussion and Q&A 4 13:40-14:10 Break, Exhibition Visit and Posters Viewing 14:10-15:40 Plenary Session 8: Diabetes and CardioRenal Disease: Can We Reduce the Impact of this Deadly Combination? Hall A Sponsored by: Worldwide Initiative for Diabetes Education 14:10 Introduction, Program Objectives and Global View of Diabetes Andrew J.M. Boulton, MD, DSc, FICP, FACP, FRCP (Program Chair), Manchester, England, UK 14:20 The Kidney and Cardiovascular Risk in Type 2 Diabetes George Bakris, Chicago, USA 14:40 Treating Heart Failure and Diabetes: What We Have Learned? Martin Rutter, MD, FRCP, Manchester, England, UK 15:00 Improving Outcomes in Diabetes with Management beyond Glucose Control Therapies Philip Home, DM, DPhil, Newcastle, England, UK 15:20 Panel Discussion and Q&A 15:40-17:15 Plenary Session 9: Diabetes and the Heart Hall A Chairs: Pavel Hamet, Jadhav Uday 15:40 Diabetes and CV Risk Evaluation-Best Strategy in Clinical Practice Uday Jadhav, India 16:00 Fibromuscular Dysplasia: an Enigmatic Disease Peter de Leeuw, The Netherlands 16:20 Cardio and Renoprotective Properties of Novel Antdiabetic Drugs Bruno Watschinger, Austria 16:40 Proinflammatory Cytokines: Emerging Therapeutic Targets for Arterial Hypertension Mohammad Bassim, Iraq 17:00 Panel Discussion and Q&A 15:40-16:40 Parallel Abstract Session Hall B Chairs: Brian Rayner, Alexander Prejbiz 5 17:15-18:50 Plenary Session 10: Precision Medicine – a Bridge to the Future Hall A Chairs: Arnas Karuzas, Vaiva Lesauskaite 17:15 Dilatative Pathology of Ascending Aorta: Questions to be answered Vaiva Lesauskaite, Lithuania 17:35 Pharmacogenomics to Tailor Drug Therapy: the Right Drug for the Patient Vacis Tatarunas, Lithuania 17:55 Artificial Intelligence in Cardiovascular Imaging Modalities Arnas Karuzas, Lithuania 18:15 Next Generation Sequencing in Cardiology Karolis Sablauskas, Lithuania 18:35 Panel Discussion and Q&A 6 Sunday, 22 November, 2020 Central European Time (CET) 08:30-10:25 Plenary Session 11: Hypertension and Organ Target Damage Hall A Chairs: Maricin Adamczak, Cetin Erol 08:30 Prenatal Programming in Pathogenesis of Hypertension Marcin Adamczak, Poland 08:50 Prehypertension in the Czech population, the Czech Post-MONICA Study Renata Cifkova, Czech Republic 09:10 Is Blood Pressure Variability a Risk Factor for Cardiovascular Diseases Gianfranco Parati, Italy 09:30 Nonalcoholic Fatty Liver Disease and the Heart Cetin Erol, Turkey 09:50 Panel Discussion and Q&A 08:30-10:00 Parallel Poster Session Hall B 10:05-10:20 Break, Exhibition Visit and Posters Viewing 10:20-11:35 Plenary Session 12: Hypertension and Organ Target Damage Hall A Chairs: Michael Bursztyn, Sekib Sokolovic 10:20 Glomerular Hyperfiltration and Cardiovascular Risk Ana Jelacovic, Croatia 10:40 Visceral Adiposity, Hypertension and Kidney Disease Marius Miglinas, Lithuania 11:00 Elastic and Stiffening Components of Pulse Pressure and their Effect on Outcome Differs by Age Michael Bursztyn, Israel 11:20 Panel Discussion and Q&A 7 11:35-12:55 Plenary Session 13: Systematc Approach to Cardiovascular Disease Management Hall A Chairs: Olivija Gustiene, Gediminas Urbonas 11:35 Primary Prevention of Cardiovascular Risk in Lithuania – Results from EUROASPIRE V Survey Gediminas Urbonas, Lithuania 11:55 Heart Failure Program in Lithuania Jelena Celutkiene, Lithuania 12:15 Management of Acute Coronary Syndromes in Lithuania Olivija Gustiene, Lithuania 12:35 Panel Discussion and Q&A 12:50-13:00 Closing Remarks Hall A Reuven Zimlichman, Rimvydas Slapikas 8 .